Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...

Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Researchers believe nearly 25,000 hospital visits occurred ... and constipation. The known risks associated with use of Ozempic are reflected in the FDA-approved product labeling." ...

Recent research suggests that Ozempic and other GLP-1 receptor agonists, commonly used for weight loss, may offer unexpected ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

Ozempic has gained fame as a powerful drug for ... vulgatus, were more likely to crave sweets and had a greater risk of developing diabetes. This suggests that gut health may play a much bigger ...

The announcement follows new research that suggested drugs like Wegovy, Mounjaro and Ozempic slashed the risk of contracting the disease. Scientists from Israel said the drugs, also known as GLP ...